Genomelabs Bio Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Genomelabs Bio Private Limited

Genomelabs Bio Private Limited, a active private limited company, was established on 25 April 2016 in Hyderabad, Telangana, India. Engaging in preventive health supplements within the trade sector, it holds CIN: U73100TG2016PTC109185. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.

It upholds a compliant status. Employing 42 professional, Its leadership includes Nagaraju Pathapati (Managing Director), Ashok Kumar Desu (Whole-Time Director). Past directors included Madhu Thokala, Suresh Raju Patapati, Nagaraju Pathapati. It holds ₹18.19 Cr open charges and ₹1.40 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D.No.8-2-120/86/9/4/28, Plot No.28 Rao & Raju Colony, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100TG2016PTC109185

  • Registration Number

    109185

  • Incorporation Date

    25 April 2016

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹20.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 20.00 Cr
  • Company Age 9 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 18.19 Cr
  • Satisfied Charges ₹ 1.40 Cr
  • Revenue Growth **** -40.21%
  • Profit Growth **** -757.04%
  • Ebitda **** -146.98%
  • Net Worth -147.99%
  • Total Assets -11.77%
Company report

Genomelabs Bio Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genomelabs Bio Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genomelabs Bio Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagaraju Pathapati Managing Director 25 Apr 2016 Current
Ashok Kumar Desu Whole-Time Director 26 Apr 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 01 May 2016 Past
Pramod Abcsdd Director 26 Apr 2016 Past
Pramod Abcsdd Additional Director 09 Nov 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genomelabs Bio.

Genomelabs Bio Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.21% decrease. The company also saw a substantial fall in profitability, with a 757.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 147.99%.

Genomelabs Bio revenue growth over time
Genomelabs Bio profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -40.21%
*******
*******
*******
*******
Revenue from Operations
*******
 -45.71%
*******
*******
*******
*******
Total Assets
*******
 -11.77%
*******
*******
*******
*******
Profit or Loss
*******
 -757.04%
*******
*******
*******
*******
Net Worth
*******
 -147.99%
*******
*******
*******
*******
EBITDA
*******
 -146.98%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genomelabs Bio?

In 2023, Genomelabs Bio had a promoter holding of 99.50% and a public holding of 0.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹181,949,510.00

Satisfied Charges

₹14,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 18.19 Cr
Latest Charge Details
Date Lender Amount Status
27 Jan 2025 Others ₹1.52 Cr Open
28 Aug 2024 Others ₹2.10 Cr Open
13 Oct 2021 Others ₹14.57 Cr Open
23 Feb 2017 Others ₹1.40 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Genomelabs Bio?

Genomelabs Bio has a workforce of 42 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genomelabs Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomelabs Bio's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genomelabs Bio
Recent Activity within the Organization
  • Annual General Meeting

    Genomelabs Bio Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 14.57 Cr registered on 13 Oct 2021 with Charge ID 100494614 was modified on 23 May 2025. was documented.

  • Balance Sheet

    Progress on Genomelabs Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.52 Cr with Charge ID 101040815 was registered on 27 Jan 2025. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.10 Cr with Charge ID 100972903 was registered on 28 Aug 2024. was documented.

  • Director Appointment

    The activity Naveen Kumar Kotla was appointed as a Company Secretary was appointed as a Company Secretary on 10 Nov 2023 & has been associated with this company since 2 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genomelabs Bio Private Limited?

The CIN of Genomelabs Bio Private Limited is U73100TG2016PTC109185.

Where is Genomelabs Bio Private Limited headquartered?

Genomelabs Bio Private Limited is headquartered at D.No.8-2-120/86/9/4/28, Plot No.28 Rao & Raju Colony, Banjara Hills, Hyderabad, Telangana, 500034.

When was Genomelabs Bio Private Limited incorporated?

Genomelabs Bio Private Limited was incorporated on 25 April 2016.

Who are the current directors of Genomelabs Bio Private Limited?

The current directors of Genomelabs Bio Private Limited are

What is the primary industry of Genomelabs Bio Private Limited?

The primary industry of Genomelabs Bio Private Limited is Trade.

Is Genomelabs Bio Private Limited a listed company?

Genomelabs Bio Private Limited is unlisted.

What is the capital structure of Genomelabs Bio Private Limited?

The authorized capital of Genomelabs Bio Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.

What is the compliance status of Genomelabs Bio Private Limited?

The compliance status of Genomelabs Bio Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available